G6PD Test at Biotech Lahore Lab

G6PD Test at Biotech Lahore Lab

The Glucose-6-Phosphate Dehydrogenase (G6PD) test is a specialized diagnostic laboratory investigation that measures the levels of the G6PD enzyme in a patient’s red blood cells. G6PD is a vital cytosolic enzyme that plays a critical role in the pentose phosphate pathway, particularly within erythrocytes. This enzyme is responsible for producing NADPH, which in turn maintains glutathione in its reduced state. Reduced glutathione acts as a primary antioxidant, shielding red blood cells from oxidative stress and preventing premature hemolysis. When a patient has a G6PD deficiency, their red blood cells become highly susceptible to oxidative damage caused by certain infections, medications, or foods, leading to acute hemolytic anemia.

At Biotech Lahore Lab, located in Lahore, Pakistan, this diagnostic test is performed using advanced automated biochemistry analyzers. The laboratory utilizes state-of-the-art spectrophotometric and kinetic assay technologies to ensure highly precise and reproducible quantitative measurements of G6PD enzyme activity. Evaluating G6PD levels is of paramount clinical importance, particularly in regions where hereditary enzyme deficiencies are prevalent. By identifying a deficiency early, healthcare providers can offer vital preventive counseling, helping patients avoid triggers that could precipitate life-threatening hemolytic crises. The diagnostic value of this test lies in its ability to confirm a suspected hereditary deficiency, guide safe pharmacological therapies, and assist in the differential diagnosis of neonatal jaundice and unexplained hemolytic anemia.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your G6PD test results at Biotech Lahore Lab, patients are advised to adhere to the following preparation guidelines:

• No Fasting Required: Fasting is generally not mandatory for a G6PD blood test. You may eat and drink normally prior to the sample collection unless instructed otherwise by your physician.
• Timing of the Test: It is highly critical that this test is not performed immediately during or shortly after an acute hemolytic episode. During a hemolytic crisis, older red blood cells with lower enzyme levels are destroyed first, leaving behind younger reticulocytes which naturally contain higher levels of G6PD. Testing during this window can yield a false-normal result. It is recommended to wait several weeks after an acute episode.
• Blood Transfusion History: Inform the laboratory staff if you have received a blood transfusion within the last 3 months. Transfused donor red blood cells can temporarily mask a G6PD deficiency, leading to inaccurate test results.
• Medication Disclosure: Provide a complete list of all medications, over-the-counter drugs, and herbal supplements you are currently taking, as certain oxidative drugs can interfere with clinical interpretation.

During the Procedure

The G6PD test is a straightforward outpatient laboratory procedure. Upon arriving at Biotech Lahore Lab, you will be guided to a comfortable phlebotomy station. A certified phlebotomist will verify your identity and explain the venipuncture process. The phlebotomist will locate a suitable vein, typically in the antecubital fossa of your arm, and cleanse the area with an antiseptic swab to prevent contamination. A sterile, single-use needle will be inserted into the vein to collect a small whole blood sample into an EDTA (lavender-top) or heparinized tube. The entire sample collection process takes less than five minutes. After the needle is removed, gentle pressure will be applied to the puncture site with a sterile cotton ball, followed by the application of an adhesive bandage. The procedure is safe, minimally invasive, and carries negligible risks, such as minor bruising or localized discomfort at the needle insertion site.

When is a G6PD Test Performed?

Investigating Neonatal Jaundice

Neonatal hyperbilirubinemia is a common clinical presentation in newborns. However, severe, prolonged, or early-onset jaundice within the first 24 hours of birth can indicate an underlying pathological cause such as G6PD deficiency. Pediatricians request this test for newborns showing signs of pathological jaundice to prevent bilirubin-induced neurologic dysfunction (kernicterus). Identifying the deficiency early allows neonatologists to implement timely phototherapy or exchange transfusions, safeguarding the infant’s neurological development.

Evaluating Acute Hemolytic Anemia

When a patient presents with sudden-onset symptoms of anemia, such as severe fatigue, pallor, shortness of breath, and dark-colored urine, clinicians suspect acute hemolytic anemia. A G6PD test is requested to determine if an inherited enzyme deficiency is the underlying cause of this rapid red blood cell destruction. Identifying G6PD deficiency as the root cause helps hematologists manage the acute phase effectively and establish a long-term management plan to prevent future hemolytic episodes.

Prior to Prescribing Oxidative Medications

Certain essential medications are known to induce oxidative stress in red blood cells. Before initiating treatment with drugs such as antimalarials (e.g., primaquine), sulfones (e.g., dapsone), sulfonamides, or certain high-dose antibiotics, physicians routinely order a G6PD test. Screening patients beforehand ensures that those with a deficiency are not prescribed these high-risk medications, thereby preventing drug-induced hemolytic anemia and ensuring patient safety during pharmacological therapy.

Investigating Hemolysis After Dietary Triggers

Ingestion of fava beans (Vicia faba) can trigger a severe hemolytic reaction known as favism in individuals with G6PD deficiency. When a patient, particularly a young child, presents with acute hemolytic symptoms shortly after consuming fava beans or foods containing them, a G6PD test is clinically indicated. Confirming the diagnosis allows healthcare providers to educate the family on strict dietary restrictions to avoid future accidental exposures.

Differential Diagnosis of Unexplained Splenomegaly

An enlarged spleen (splenomegaly) can result from the chronic destruction of abnormal red blood cells. When patients present with unexplained splenomegaly accompanied by mild, chronic, or episodic anemia, clinicians include G6PD testing in their diagnostic workup. This helps differentiate G6PD deficiency from other red blood cell membrane defects, hemoglobinopathies, or autoimmune hemolytic conditions, leading to an accurate diagnosis and appropriate clinical management.

What Does a G6PD Test Detect?

The G6PD test is designed to measure the quantitative activity of the glucose-6-phosphate dehydrogenase enzyme within erythrocytes. Specifically, the test detects and evaluates:

• Normal Enzyme Activity: Confirms sufficient levels of G6PD, indicating that red blood cells possess adequate antioxidant defense mechanisms against oxidative stressors.
• Severe G6PD Deficiency (Class I): Detects extremely low or virtually absent enzyme activity, often associated with chronic nonspherocytic hemolytic anemia even in the absence of oxidative triggers.
• Moderate to Severe Deficiency (Class II): Identifies significantly reduced enzyme levels, typically seen in populations of Mediterranean descent, which can lead to severe acute hemolytic crises upon exposure to triggers.
• Moderate Deficiency (Class III): Detects moderately decreased enzyme activity, commonly observed in African descent populations, where hemolysis is usually self-limiting and associated with specific drug exposures.
• Asymptomatic Carrier Status: Helps identify heterozygous females who may have variable enzyme levels due to random X-chromosome inactivation (lyonization), requiring careful clinical correlation.
• Drug-Induced Hemolysis Risk: Evaluates whether a patient can safely tolerate oxidative medications without risking acute intravascular hemolysis.
• Dietary Sensitivity (Favism): Assesses the risk of severe hemolytic reactions following the consumption of fava beans.

Turnaround Time and Report Access at Biotech Lahore Lab

At Biotech Lahore Lab, we understand the clinical urgency associated with diagnostic testing. The G6PD test is processed using automated, high-throughput systems to ensure both speed and accuracy. Typically, G6PD test reports are finalized and verified by our consultant pathologists within 24 to 48 hours of sample collection. Patients and referring physicians are notified via SMS once the report is ready. Reports can be accessed online through the official Biotech Lahore Lab patient portal, downloaded as a secure PDF, or collected in person from our main facility or designated collection centers across Lahore.

G6PD Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
G6PD Enzyme Activity	Within established reference range (typically 7.0 – 20.5 U/g Hb, subject to lab-specific reference values)	Decreased enzyme activity (indicative of G6PD deficiency; categorized into Class I, II, or III)
Red Blood Cell (RBC) Count	Normal range (4.5 – 5.9 million/mcL for men; 4.1 – 5.1 million/mcL for women)	Decreased RBC count during an active hemolytic episode
Hemoglobin (Hb) Levels	Normal range (13.5 – 17.5 g/dL for men; 12.0 – 15.5 g/dL for women)	Significantly reduced hemoglobin levels during acute hemolytic crises
Reticulocyte Count	Normal range (0.5% – 1.5% of total RBCs)	Elevated reticulocyte count (indicates bone marrow compensating for active hemolysis)
Serum Bilirubin (Total & Indirect)	Normal range (Total: 0.2 – 1.2 mg/dL; Indirect: < 0.8 mg/dL)	Elevated total and indirect bilirubin levels (indicates active breakdown of red blood cells)
Haptoglobin Levels	Normal range (30 – 200 mg/dL)	Markedly decreased or undetectable haptoglobin (indicates significant intravascular hemolysis)
Peripheral Blood Smear	Normal RBC morphology with no abnormal inclusions	Presence of Heinz bodies (precipitated hemoglobin) and bite cells (degmacytes)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Biotech Lahore Lab for G6PD?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, technologists, and phlebotomists dedicated to clinical excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Biotech Lahore Lab adheres to strict internal and external quality control protocols to ensure reliable results.
• Professional Reporting: All diagnostic reports are thoroughly reviewed and verified by consultant pathologists before release.
• Modern Diagnostic Approach: We utilize advanced automated systems and modern laboratory methodologies for precise enzyme quantification.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and stress-free environment for patients of all ages.
• Convenient Location: Strategically situated in Lahore, our main lab and collection points are easily accessible to patients across the city.
• Commitment to Accurate Diagnosis: We are dedicated to providing timely and highly accurate diagnostic insights to support clinical decision-making.